Downregulation in expression of the c-myc proto-oncogene is an early molecular event in differentiation of murine C2C12 myoblasts into multinucleated myotubes. During differentiation, levels of c-myc mRNA decrease 3-to 10-fold despite a lack of change in its transcription rate. To identify cis-acting elements that target c-myc mRNA for downregulation during myogenesis, we stably transfected C2C12 cells with mutant myc genes or chimeric genes in which various myc sequences were fused to the human ␤-globin gene or to the bacterial chloramphenicol acetyltransferase (CAT) gene. Deletion of coding sequences from myc exon 2 or exon 3 abolished downregulation of myc mRNA during myogenic differentiation, while deletion of introns or sequences in the 5 or 3 untranslated regions (UTRs) did not, demonstrating that coding elements in both exons 2 and 3 are necessary for myc mRNA downregulation. Fusion of coding sequences from either myc exon 2 or 3 to ␤-globin mRNA conferred downregulation onto the chimeric mRNA, while fusion of myc 3 UTR sequences or coding sequences from CAT or ribosomal protein L32 did not, demonstrating that coding elements in myc exons 2 and 3 specifically confer downregulation. These results present the apparent paradox that coding elements in either myc exon 2 or myc exon 3 are sufficient to confer downregulation onto ␤-globin mRNA, but neither element alone was sufficient for myc mRNA downregulation, suggesting that some feature of ␤-globin mRNA may potentiate the regulatory properties of myc exons 2 and 3. A similar regulatory function is not shared by all mRNAs because fusion of either myc exon 2 or myc exon 3 to CAT mRNA did not confer downregulation onto the chimeric mRNA, but fusion of the two elements together did. We conclude from these results that two myc regulatory elements, one exon 2 and one in exon 3, are required for myc mRNA downregulation. Finally, using a highly sensitive and specific PCR-based assay for comparing mRNA levels, we demonstrated that the downregulation mediated by myc exons 2 and 3 results in a decrease in cytoplasmic mRNA levels, but not nuclear mRNA levels, indicating that regulation is a postnuclear event.
The c-myc proto-oncogene encodes a nuclear phosphoprotein thought to function as a transcription factor that regulates genes important for cell proliferation and differentiation (for a review, see reference 25). c-myc expression increases in cells stimulated to proliferate (29) , and cells expressing c-myc constitutively (1) or microinjected with c-myc protein (28) have a decreased requirement for growth factor. Conversely, repression of c-myc expression inhibits cell entry into S phase (24) . A number of genes thought to encode regulators of cell cycling, including ␣-prothymosin (17), ornithine decarboxylase (2, 3), cyclin D1 (39) , and cdc25A (19) , are putative targets of c-Myc transcriptional control. c-myc expression decreases in many cells induced to growth arrest and differentiate (15, 30) , suggesting a role for c-myc downregulation in cell differentiation. This finding is supported by the observations that constitutive c-myc expression prevents differentiation (11, 18, 22) , while repression of c-myc expression induces differentiation (41, 49) . These studies suggest that regulated expression of c-myc plays a pivotal role in determining cell growth and differentiation behavior.
Both transcriptional (4, 9, 23, 36, 38) and posttranscriptional (6, 13-15, 30, 45) mechanisms regulate c-myc expression, depending on the cell type examined and the culture conditions to which the cells are exposed. c-myc transcription can be modulated by the activity of upstream promoters and enhancers (21, 33, 36) . Alternatively, in many cell lines, including murine fibroblasts (38) and HL60 (23) , MEL (36) , small-cell lung cancer (31) , and B-lymphoid (9) cells, nuclear run-on assays indicate that c-myc expression can be regulated by attenuation of transcription near the border of exon 1 and intron 1, resulting in blockade of transcript elongation or premature termination. In other cell lines, such as C2C12 myoblasts (45) , Daudi Burkitt's lymphoma cells (13, 30) , and F9 teratocarcinoma cells (14, 15) , c-myc expression is regulated through posttranscriptional mechanisms, presumably acting at the level of mRNA turnover. Critically important for rapid regulation of c-myc mRNA is its short half-life (15 to 30 min) (12, 27) , which allows cells to rapidly alter c-myc expression downward during cell differentiation (6, 13-15, 30, 45) or upward during mitogen stimulation (46) .
Regulated RNA stability plays an important role in controlling levels of other mRNAs besides c-myc and can occur through a variety of mechanisms. A stem-loop structure in the 3Ј untranslated region (UTR) of histone mRNA is necessary for its translation-dependent turnover and tightly couples histone mRNA levels to the cell's position in the cell cycle and DNA synthesis (20) . Stem-loop structures termed iron-responsive elements in the 3Ј UTR of transferrin receptor mRNA regulate its turnover. Two iron-regulatory proteins that bind to the iron-regulatory elements in an iron-poor environment, stabilize the transferrin receptor mRNA, and increase its steadystate level have been characterized (8, 37, 42) ; in an iron-rich environment, the unprotected mRNA is rapidly degraded. Autoregulation of ␤-tubulin mRNA levels depends on translation of its first four codons. Excess free ␤-tubulin subunits target the ␤-tubulin mRNA for accelerated turnover through recognition of the encoded tetrapeptide rather than through recog-nition of the RNA sequence or structure (48) . Thus, posttranscriptional regulation of cellular mRNAs can occur through a variety of mechanisms.
We have sought to identify mechanisms by which c-myc expression is posttranscriptionally downregulated during C2C12 myogenic differentiation. We previously demonstrated that sequences in the myc mRNA 3Ј UTR determine its turnover rate and steady-state levels in C2C12 cells under normal growth conditions. However, these sequences are dispensable for downregulation of c-myc mRNA levels during differentiation (45, 47) . In the present study, we demonstrate that coding sequences in both myc exon 2 and myc exon 3 are important for its downregulation during myoblast differentiation. We also demonstrate that downregulation occurs in the cytoplasm and not in the nucleus, supporting the idea that regulation occurs by accelerated mRNA turnover.
MATERIALS AND METHODS
Plasmid constructions. Salient features of the plasmids used in our study are diagrammed in Fig. 1 . CM19 was previously described (47) and is a pUC-based plasmid that contains all three exons of human c-myc from the XhoI site (between the P1 and P2 promoters) to the EcoRI site (3Ј to exon 3) under the transcriptional control of the Moloney murine leukemia virus (MLV) long terminal repeat (LTR). myc(X/N) was previously described (47) and contains myc sequences from the XhoI site to the NsiI site 75 nucleotides (nt) 3Ј to the translation termination codon fused to the simian virus 40 T-antigen polyadenylation signal (SVpA). The construction of plasmids myc(⌬41-178) and myc(⌬265-433), in which myc codons 41 to 178 and 265 to 433 were deleted, was previously described (44) . myc (T/N) was created by ligating the SVpA to the NsiI site of MLV-m23 (45) and contains myc cDNA sequences from the ThaI site 5 nt upstream of the exon 2 translation initiation codon to the NsiI site. Codons 41 to 178 were deleted from myc(T/N) by removing the PstI-PstI fragment to create
myc(T/N)(⌬41-178). To create myc(T/N)(⌬265-433), myc codons 265 to 433 were deleted from myc(T/N) by substituting the ClaI-NsiI fragment of myc(⌬265-433).
Construction of the ␤-globin-myc plasmids ␤Gm434SVpA, ␤Gm434mycpA, ␤Gm263SVpA, and ␤Gm(40-263)SVpA and their nomenclature were previously described (47) . These genes contain an MLV-␤-globin backbone encoding the first 140 (of 146) globin amino acids fused to variable myc sequences. In ␤Gm434SVpA, MLV-␤-globin was fused in frame to myc codon 434 and includes the last six myc codons and first 75 nt of the myc 3Ј UTR and uses the SVpA. The other genes were created from ␤Gm434SVpA with the following modifications: in ␤Gm434mycpA, the entire myc 3Ј UTR and flanking sequences to the EcoRI site were substituted for the SVpA; in ␤Gm263SVpA, almost all myc exon 3 coding sequences (from codon 263 to the NsiI site in myc exon 3) were fused in frame to globin; and in ␤Gm(40-263)SVpA, myc cDNA sequences from codons 40 to 263 (most exon 2 coding sequences and the first 10 codons in exon 3) were fused in frame to globin. ␤Gm263SVpARI Ϫ was created by introducing a C-to-T mutation by site-directed mutagenesis into ␤-globin codon 122, which destroyed an EcoRI site but preserved the encoded amino acid (phenylalanine). ␤Gm40G was created by substituting the XhoI-EcoRI fragment of In40 (44) for the same fragment in ␤Gm434SVpA. ␤Gm40G(⌬41-178) was created from ␤Gm40G by removing the PstI-PstI fragment of myc exon 2. ␤Gm40G(⌬265-433) was created by substituting the ClaI-EcoRI fragment of myc(⌬265-433) for the same fragment in ␤Gm40G.
In ␤G-rpL32 and ␤G-CAT (47), the MLV-␤-globin backbone was fused to the first 133 (of a total of 135) codons of ribosomal protein L32 (rpL32) (16) or to the last 181 (of a total of 219) codons of the bacterial gene encoding chloramphenicol acetyltransferase (CAT), respectively; both plasmids use the SVpA.
CAT-myc fusion genes were constructed by fusing the NcoI-EcoRI fragment of ␤-globin-myc plasmids into the NcoI-BamHI site of MLV-CAT-SVpA (45) and contain sequences encoding the first 173 CAT amino acids fused in frame to variable myc sequences via a short linker with a 5Ј NcoI site and a 3Ј XhoI site. (See reference 47 for introduction of an NcoI site at ␤-globin codons 140 and 141.) They were constructed identically to ␤-globin-myc plasmids except that the intronless CAT gene was substituted for the ␤-globin gene. CAT-myc fusion genes were named similarly to ␤-globin-myc genes: in CAT-myc(40-439), CAT sequences were fused in frame to myc cDNA sequences from codon 40 to the NsiI site followed by the SVpA; CAT-myc(40-263) linked myc codons 40 to 263 in frame to CAT followed by the SVpA; and CAT-myc263 linked in frame myc sequences from codon 263 to the NsiI site to CAT followed by the SVpA.
Cell culture and DNA transfection. All experiments were performed with murine C2C12 myoblasts (7) obtained from the American Type Culture Collection (Rockville, Md.) and maintained in Dulbecco's minimum essential medium (DMEM) supplemented with 10% fetal calf serum, 5% CO 2 , penicillin, and streptomycin. Plasmids containing test genes were stably cotransfected into C2C12 cells with a plasmid containing a Neo r gene, using the calcium phosphate method. After selection in 400 g of G418 (Gibco) per ml, pools of 25 to 50 surviving colonies were expanded for study. Differentiation assays were performed as previously described (45) . Briefly, stably transfected C2C12 cells were seeded at subconfluent density into multiple culture plates containing DMEM supplemented with 10% fetal calf serum and antibiotics. Cells were cultured to confluence and then induced to differentiate into multinucleated myotubes by changing the medium to DMEM containing 2% horse serum.
Analysis of mRNA levels during differentiation in stably transfected cells. Total cytoplasmic mRNA was isolated on serial culture days as previously described (47) , and mRNA levels were determined by Northern analysis using the glyoxal method (35) . RNA was electroblotted to Hybond N (Amersham) and UV cross-linked. Hybridizations were carried out by modifications of the method of Church and Gilbert (10), using probes labeled by random priming. Human myc mRNAs were probed with a human c-myc exon 1 probe (XhoI-to-PvuII fragment) or a human c-myc exon 2ϩ3 cDNA probe from pSP65mycIIA (44) . ␤-Globin chimeric mRNAs were probed with a full-length human ␤-globin cDNA fragment from pSP␤c (gift from Stephen Liebhaber). CAT chimeric mRNAs were probed with the HindIII-BamHI fragment of MLV-CAT-SVpA (45) . C2C12 c-myc mRNA was probed with a murine c-myc exon 1 probe (BamHI-to-SacI fragment) or a human c-myc exon 2ϩ3 cDNA probe from pSP65mycIIA (44) . rpL32 mRNA was probed with a full-length cDNA probe (16) . Northern blots were analyzed on a Molecular Dynamics (Sunnyvale, Calif.) PhosphorImager using ImageQuant software, and the relative levels of myc, globin-myc, and CAT-myc mRNAs during differentiation were determined by normalizing for RNA loading by reference to the level of rpL32 mRNA unless otherwise stated. A decrease in endogenous c-myc mRNA levels by at least threefold after cells reached confluence and were induced to differentiate was considered to signify that myc mRNA downregulation had occurred, and mRNA from the transgene was considered downregulated if its normalized level decreased at least threefold during differentiation. The Northern blots shown are representative of the results obtained on each stably transfected cell line. The bar graphs shown depict the levels of myc, globin-myc, and CAT-myc mRNAs relative to mRNA levels in preconfluent, undifferentiated cells after normalization for RNA loading by reference to the level of rpL32 mRNA unless otherwise stated. The Bio-Rad (Hercules, Calif.) photodocumentation system and Molecular Analyst software were used to quantitate relative RNA loading, using ethidium bromide-stained gels.
RT-PCR؉1 assay of comparative mRNA abundance. The reverse transcription (RT)-PCRϩ1 assay for comparing the abundances of two ␤-globin-containing mRNAs was performed as previously described (47), with minor modifications. Total cytoplasmic RNA was extracted from transfected C2C12 cells as previously described. To isolate nuclear RNA, nuclei were isolated after C2C12 cell lysis in nuclear lysis buffer (10 mM Tris-HCl [pH 7.4], 10 mM NaCl, 5 mM MgCl 2 , 0.5% Nonidet P-40). After nuclei were washed in nuclear lysis buffer, nuclear RNA was isolated by using Trizol Reagent (Gibco BRL). Sequencespecific reverse transcription of cytoplasmic and nuclear RNAs was performed by priming with oligonucleotide ␤G3ЈRev (see below), using M-MLV reverse transcriptase (Gibco BRL). PCR amplification of cDNA was performed with Taq polymerase (Promega) in 50 mM Tris-HCl (pH 9.0)-20 mM (NH 4 ) 2 SO 4 -1.5 mM MgCl 2 -200 mM deoxynucleoside triphosphates-1 mM oligonucleotide primers on a PTC-100 thermal cycler (MJ Research, Cambridge, Mass.). A 214-bp sequence of ␤-globin cDNA was amplified by using oligonucleotide primers ␤GF2 and ␤G3ЈRev (see below) under the following conditions: 30 cycles of 92ЊC for 30 s, 62ЊC for 15 s, and 72ЊC for 15 s. A ϩ1 cycle was conducted with a 32 P-end-labeled nested primer, ␤GF1, and the products were restricted with EcoRI and resolved by electrophoresis. A radiolabeled RT-PCR-generated 329-bp DNA fragment containing a unique EcoRI site was added to each EcoRI digestion reaction to indicate complete digestion of the RT-PCRϩ1 products. The relative abundances of the RT-PCRϩ1 products, and hence of the mRNAs, were quantitated on a Molecular Dynamics PhosphorImager using ImageQuant software. The primers used in this study were ␤GF2 (5ЈAAGTGCTCGGTGCC TTTAGTGA3Ј), ␤G3ЈRev (5ЈACACCAGCCACCACTTTCTGA3Ј), and ␤GF1 (5ЈCAAGGGCACCTTTGCCACACT3Ј).
RESULTS
Protein coding sequences in exons 2 and 3 are necessary for downregulation of c-myc mRNA in differentiating C2C12 cells. When murine C2C12 myoblasts are induced to differentiate into multinucleated myotubes by culturing to confluence and changing to mitogen-poor culture media, the level of c-myc mRNA is downregulated over 12 to 24 h (Fig. 2 ) through posttranscriptional mechanisms (45) . While the mRNAs of housekeeping genes such as those encoding rpL32 and glyceraldehyde-3-phosphate dehydrogenase can be variably downregulated (0 to 50%, normalized to 18S and 28S RNA levels on ethidium bromide-stained gels), c-myc mRNA is downregulated 3-to 10-fold compared to these housekeeping mRNAs. The magnitude of c-myc mRNA downregulation generally cor-FIG. 1. Schematic diagram of recombinant genes used in these studies. Construction of these genes is outlined in Materials and Methods. The structural features of these genes and the shading patterns of exonic sequences are indicated at the bottom. An NcoI restriction site was introduced into exon 3 of MLV-␤-globin, which allowed construction of chimeric ␤-globin genes. Endonuclease restriction sites used in construction are indicated as follows: NsiI, N; NcoI, Nc; EcoRI, R; ThaI, T; and XhoI, X. The NcoI site in MLV-␤-globin exon 3 was introduced by site-directed mutagenesis (47) . 40 and 263 designate myc coding sequences from codons 40 to 263 and from codon 263 to the NsiI site 75 nt downstream of the translation termination codon, respectively. The translation termination codon in each construct is depicted by an asterisk. These constructs were stably transfected into C2C12 cells, and downregulation of their mRNAs during myoblast differentiation was determined as outlined in Materials and Methods. The maximum fold downregulation of their mRNAs is shown to the right of each construct and compared to the fold downregulation of endogenous murine c-myc mRNA. 3ЈUT, 3Ј UTR; SV40, simian virus 40. relates with the percentage of cells that undergo morphological differentiation with greater than threefold downregulation seen in cultures in which the majority of cells have morphologically differentiated (unpublished observations). As shown in Fig. 2 , levels of c-myc mRNA were markedly downregulated as cells reached confluence (day 2 of culture) and continued to decrease after cells were changed to mitogen-poor medium on day 2. This continued decrease in levels of c-myc mRNA likely results from asynchronous differentiation. We previously demonstrated that a transfected full-length human c-myc gene or a human c-myc gene under the transcriptional control of the MLV LTR encodes an mRNA that is regulated like endogenous murine c-myc mRNA when these cells are induced to differentiate (45) . We sought to identify the cis-acting elements targeting c-myc mRNA for downregulation.
As a first step in the identification of regulatory elements, we analyzed the regulation of human myc mRNAs containing deletion mutations. C2C12 cells were stably transfected with (i) CM19, an almost full-length human c-myc gene; (ii) myc(X/N), a mutant human myc gene from which most 3Ј UTR sequences were deleted; (iii) myc(⌬265-433), a mutant from which most exon 3 coding sequences were deleted; or (iv) myc(⌬41-178), a mutant from which most of exon 2 was deleted. Twenty-five to 50 clones were pooled for analysis to ensure that clonal variation did not skew results. Cytoplasmic RNA was isolated on serial days from subconfluent, undifferentiated cells, confluent cells, and cells induced to differentiate. Northern analysis demonstrated that mRNAs from CM19 and myc(X/N) were maximally downregulated 4.9-and 3.0-fold, respectively, during C2C12 differentiation, similar to the 8.6-and 3.3-fold downregulation of endogenous c-myc mRNA in the respective cells (all normalized to rpL32 mRNA) ( Fig. 1 and 3A and B). The modest increase in levels of c-myc and CM19 mRNAs seen in later cultures (Fig. 3A , culture days 4 and 5) likely represents outgrowth of undifferentiated cells. In contrast, levels of myc(⌬41-178) and myc(⌬265-433) mRNAs were essentially unchanged or increased slightly during differentiation ( Fig. 1 and  3C and D) . Endogenous c-myc mRNA was downregulated 5.4-and 3.2-fold in myc(⌬41-178) and myc(⌬265-433) stable transfectants, respectively, demonstrating that the cellular regulatory machinery was mobilized. Repeat differentiation assays yielded similar results (Fig. 1) , leading to the conclusion that both exon 2 and exon 3 coding sequences are necessary for myc FIG. 2 . c-myc mRNA is markedly downregulated during C2C12 myogenic differentiation. C2C12 cells were seeded at low density into multiple culture plates, cultured to confluence, and induced to differentiate in differentiation medium (DMEM containing 2% horse serum). Northern analysis was performed on cytoplasmic RNA isolated on serial days beginning the day after cells were plated. Cells were subconfluent on day 1 and confluent on day 2. The medium was changed to differentiation medium on day 2; therefore, day 3, 4, and 5 cells had been exposed to differentiation medium for 1, 2, and 3 days, respectively. The left panel displays an autoradiograph of a Northern blot probed for c-myc mRNA by using a murine c-myc exon 1 probe (BamHI-to-SacI fragment) and for rpL32 mRNA by using a full-length cDNA probe (16) . The ethidium bromidestained agarose gel is shown below the autoradiographs. The right panel displays the relative abundance of c-myc and rpL32 mRNAs compared to their levels in preconfluent cells. Levels shown were normalized to ethidium bromide staining to correct for RNA loading. mRNA from the transfected gene was detected by using a human c-myc exon 1 probe (XhoI-to-PvuII fragment) (Hu-myc); the endogenous murine (Mu) c-myc mRNA was detected by using a murine c-myc exon 1 probe; and rpL32 mRNA was detected by using a full-length cDNA probe (16) . RNA from untransfected C2C12 cells (lanes U) was used to demonstrate specificity of the human c-myc exon 1 probe. The bar graphs depict the levels of endogenous murine c-myc mRNA (dark bars) and transgene mRNA (light bars) relative to their mRNA levels in preconfluent, undifferentiated cells after normalization for RNA loading by reference to the level of rpL32 mRNA.
on December 28, 2017 by guest http://mcb.asm.org/ mRNA downregulation during differentiation, but 3Ј UTR sequences are dispensable. Fusion of protein coding sequences from myc exon 2 or 3 to globin confers downregulation on the chimeric mRNA during C2C12 differentiation. To identify myc sequences that target the mRNA for downregulation, we identified those that could confer regulation on human ␤-globin mRNA. C2C12 cells were stably transfected with ␤Gm434SVpA, ␤Gm(40-263)SVpA, or ␤Gm263SVpA to determine if coding sequences from myc exon 2 or 3 alone could confer regulation onto ␤-globin mRNA. Levels of ␤Gm434SVpA mRNA decreased only 1.3-fold during C2C12 differentiation, compared to a 5.5-fold downregulation of endogenous c-myc mRNA ( Fig. 1 and  4A) , which showed that ␤-globin mRNA fused in frame to myc sequences from codon 434 to the NsiI site is insufficient for downregulation. Surprisingly, both ␤Gm(40-263)SVpA and ␤Gm263SVpA mRNAs were downregulated during differentiation (5.4-and 3.6-fold, respectively, compared to 11.0-and 6.6-fold downregulation of endogenous c-myc mRNA) ( Fig. 1  and 4B and C) . This result demonstrated that coding sequences in myc exon 2 and 3 could independently downregulate ␤-globin mRNA.
To exclude the possibility that downregulation of ␤Gm(40-263)SVpA and ␤Gm263SVpA mRNAs was a nonspecific effect of fusing additional sequences to globin mRNA, C2C12 cells were stably transfected with ␤Gm434mycpA, ␤G-CAT, or ␤G-rpL32. Northern analyses of RNA isolated from these transfectants during differentiation demonstrated that myc 3Ј UTR sequences or most of the coding region from CAT or rpL32 conferred no more than 2.2-fold downregulation of globin mRNA ( Fig. 1 and 4D and E) . This result showed that downregulation of ␤Gm(40-263)SVpA and ␤Gm263SVpA mRNAs was specifically conferred by myc exon 2 or 3 coding sequences. This finding, together with the results of the myc deletion mRNA studies, present the curious situation where sequences from both myc exons 2 and 3 are needed to downregulate myc mRNA, while sequences from either exon alone can confer downregulation when fused to ␤-globin mRNA.
myc intron and noncoding mRNA sequences do not inhibit mRNA downregulation. The apparent paradox of myc and globin-myc mRNA downregulation might be explained by the presence of regulation-inhibitory sequences in myc mRNA in addition to the regulatory elements in exons 2 and 3. Such inhibitory sequences could neutralize the regulatory effects of exon 2 or 3 sequences when either element is present alone. To determine whether inhibitory sequences in other regions of myc mRNA prevent coding sequences from either myc exon 2 or myc exon 3 alone from conferring downregulation, C2C12 cells were stably transfected with myc(T/N), myc(T/N)(⌬41-178), and myc(T/N)(⌬265-433). These plasmids contain truncated myc cDNAs from which myc introns and almost all 5Ј and 3Ј noncoding sequences have been deleted. During C2C12 differentiation, myc(T/N) mRNA was downregulated 3.7-fold, similar to the 4.1-fold downregulation of endogenous c-myc mRNA ( Fig. 1 and 5A ). This result shows that only the myc coding domain (and not 5Ј and 3Ј UTR and intron sequences) is necessary for normal myc mRNA downregulation. In con-
trast, neither myc(T/N)(⌬41-178) nor myc(T/N)(⌬265-433)
mRNA was downregulated ( Fig. 1 and 5B and C), which shows that coding sequences from both myc exons 2 and 3 are needed for downregulation, even when other portions of myc mRNA are absent.
To test whether myc intron or UTR sequences inhibit downregulation of ␤-globin mRNA fused to myc exon 2 or exon 3 FIG. 4 . Coding sequences from myc exon 2 or 3, but not myc 3Ј UTR or CAT sequences, confer downregulation on ␤-globin during myoblast differentiation. Differentiation assays were conducted on C2C12 cells stably transfected with ␤Gm434SVpA, ␤Gm(40-263)SVpA, ␤Gm263SVpA, ␤Gm434mycpA, or ␤G-CAT. (See the legend in Fig. 2 for details of the assay.) Autoradiographs of Northern blots display mRNA levels in cells transfected with ␤Gm434SVpA (A), ␤Gm(40-263)SVpA (B), ␤Gm263SVpA (C), ␤Gm434mycpA (D), and ␤G-CAT (E). mRNA from the transfected gene was detected by using a full-length human ␤-globin (␤G) cDNA probe, pSP␤c; endogenous murine c-myc and rpL32 mRNAs were detected by using myc exon 2 and 3 and full-length rpL32 probes, respectively. RNA from untransfected C2C12 cells (lanes U) was used to demonstrate specificity of the human ␤-globin cDNA probe. The bar graphs depict the levels of endogenous murine c-myc mRNA (dark bars) and transgene mRNA (light bars) relative to their mRNA levels in preconfluent, undifferentiated cells after normalization for RNA loading by reference to the level of rpL32 mRNA.
sequences, C2C12 cells were stably transfected with ␤Gm40G(⌬41-178) and ␤Gm40G(⌬265-433). These plasmids contain globin fused in frame to coding sequences from myc exon 2 or 3 with myc intron 2 and 3Ј UTR sequences present. The sizes of their mRNAs on Northern blots indicated that these mRNAs were correctly spliced. During C2C12 differentiation, ␤Gm40G(⌬41-178) and ␤Gm40G(⌬265-433) mRNAs decreased 4.4-and 4.3-fold, respectively ( Fig. 1 and 6 ), which was comparable to the downregulation of endogenous c-myc mRNA. Combined with the studies of mRNAs from myc(T/N) derivatives, these results show that myc intron and UTR sequences do not inhibit mRNA downregulation. Therefore, the presence of these elements does not explain why sequences from both exons 2 and 3 are necessary for myc mRNA downregulation, and their absence does not explain why globin mRNA is regulated when fused to either exon 2 or 3 sequences.
Multiple regulatory elements are necessary for mRNA downregulation during differentiation. An alternative explanation for the conundrum seen with regulation of myc and ␤-globin-myc mRNA is that some property of ␤-globin mRNA potentiates the regulatory effects of the myc coding exons. If this is the case, fusion of myc exon 2 or 3 sequences to another heterologous mRNA might produce results different from those for globin-myc fusion mRNAs. A globin-CAT fusion mRNA was not regulated during C2C12 cell differentiation ( Fig. 1 and 4E ), suggesting that CAT mRNA does not contain a regulatory element. Therefore, we made CAT-myc(40-263), CAT-myc(263-439), and CAT-myc(40-439), which contain CAT sequences fused in frame to coding sequences from myc exon 2, exon 3, or exons 2 and 3, sequentially, and transfected them into C2C12 cells. During C2C12 differentiation, neither CAT-myc(40-263) nor CAT-myc(263-439) mRNA was downregulated significantly ( Fig. 1 and 7A and B) . However, CATmyc(40-439) mRNA was downregulated 4.0-fold ( Fig. 1 and   7C ), demonstrating that myc exons 2 and 3 together, but neither alone, confer regulation on CAT mRNA. Therefore, some property of or sequence in ␤-globin mRNA that is not shared by CAT mRNA complements the functionality of myc mRNA regulatory elements in exons 2 and 3 and allows each to impart mRNA downregulation when fused to ␤-globin mRNA individually.
mRNA downregulation mediated by myc exon 2 or 3 occurs as a postnuclear event. Previous studies have demonstrated that downregulation of c-myc mRNA during C2C12 differentiation occurs posttranscriptionally (45) , but whether it occurs in the nucleus or in the cytoplasm is unknown. To determine whether nuclear as well as cytoplasmic mRNA levels are altered during downregulation, we used an assay for comparing the relative abundances of two globin-myc fusion mRNAs. Previously, we demonstrated that the levels of two globin-myc fusion mRNAs can be compared by a sensitive and specific RT-PCRϩ1 assay (47) . After RT-PCR amplification of a 214-bp sequence of the globin-myc fusion mRNAs, an additional cycle of amplification is conducted with a radiolabeled nested primer. The product from one of the two mRNAs contains a unique EcoRI site, allowing the two products to be distinguished after digestion.
To determine whether myc exon 3-mediated mRNA downregulation is a nuclear or cytoplasmic event, C2C12 cells were stably cotransfected with ␤Gm263SVpARI Ϫ and ␤Gm434SVpA; the former contains ␤-globin fused to myc exon 3 coding sequences and encodes an mRNA downregulated during differentiation, while the latter encodes an unregulated mRNA. The comparative abundances of spliced ␤Gm434SVpA and ␤Gm263SVpARI Ϫ mRNAs in a nuclear RNA preparation were determined by RT-PCRϩ1 analysis. A single 168-nt band was produced by RT-PCRϩ1 of nuclear RNA from both undifferentiated and differentiated cells (Fig.  8A, lanes 9 and 10) , while control reactions were negative (Fig.   FIG. 5 Fig. 2 
. Deletion of introns and UTRs does not affect regulation of myc mRNAs. Differentiation assays were conducted on C2C12 cells stably transfected with myc(T/N), myc(T/N)(⌬41-178), or myc(T/N)(⌬265-433). (See the legend in

for details of the assay.) Autoradiographs of Northern blots display mRNA levels in cells transfected with myc(T/N) (A), myc(T/N)(⌬41-178) (B), or myc(T/N)(⌬265-433) (C)
. mRNA from the transfected gene was detected by using a human (Hu) c-myc exon 2 and 3 probe; the endogenous murine (Mu) c-myc mRNA was detected by using a murine c-myc exon 1 probe; and rpL32 mRNA was detected by using a full-length cDNA probe (16) . RNA from untransfected C2C12 cells (lanes U) was used to demonstrate specificity of the human c-myc exon 2 and 3 probe. The bar graphs depict the levels of endogenous murine c-myc mRNA (dark bars) and transgene mRNA (light bars) relative to their mRNA levels in preconfluent, undifferentiated cells after normalization for RNA loading by reference to the level of rpL32 mRNA.
8A, lane 2). Product derived from ␤Gm434SVpA mRNA contains an EcoRI site, and the radiolabeled portion is restricted to 119 nt after EcoRI digestion, while product from ␤Gm263SVpARI Ϫ mRNA is not cut by EcoRI and remains at 168 nt. After EcoRI digestion, the ratio of spliced nuclear ␤Gm434SVpA mRNA to ␤Gm263SVpARI Ϫ mRNAs was found to be 1.5:1 in both undifferentiated and differentiated C2C12 cells (Fig. 8A, lanes 5 and 6) . In contrast, the ratio of ␤Gm434SVpA mRNA to ␤Gm263SVpARI Ϫ mRNA in the cytoplasm was 3.0:1 in undifferentiated cells (Fig. 8A, lanes 3  and 7) , which suggests a twofold-higher cytoplasmic turnover rate for ␤Gm263SVpARI Ϫ than ␤Gm434SVpA mRNA (when the 3:1 cytoplasmic mRNA ratio is compared to the 1.5:1 nuclear ratio). This finding is consistent with our previous observations that fusion of myc exon 3 coding sequences destabilizes ␤-globin mRNA (47) . After cells were induced to differentiate, the comparative abundance in the cytoplasm changed to 8.4:1 (Fig. 8A, lanes 4 and 8) , indicating an almost threefold downregulation of ␤Gm263SVpARI Ϫ mRNA compared to ␤Gm434SVpA mRNA and a five-to sixfold-higher comparative turnover rate. Therefore, myc exon 3-mediated mRNA downregulation affects relative cytoplasmic mRNA levels but does not affect relative nuclear mRNA levels.
To determine whether myc exon 2 mediates mRNA downregulation in the nucleus or cytoplasm, ␤Gm(40-263)SVpARI Ϫ and ␤Gm434SVpA were stably cotransfected into C2C12 cells. RT-PCRϩ1 analysis of nuclear RNA demonstrated that the ratios of spliced nuclear ␤Gm434SVpA mRNA to ␤Gm(40-263)SVpARI Ϫ mRNA were similar in undifferentiated and differentiated cells (1:1 and 1:1.1; Fig. 8B , lanes 5 and 6). In the cytoplasm, the ratios were 1.1:1 in undifferentiated cells but 3.3:1 in differentiated cells (Fig. 8B,  lanes 3 and 4) . The greater comparative abundance of cytoplasmic ␤Gm434SVpA mRNA compared to ␤Gm(40-263)SVpARI Ϫ mRNA following differentiation indicates a threefold selective downregulation of ␤Gm(40-263)SVpARI Ϫ mRNA, probably due to a threefold-higher cytoplasmic turnover rate. These results also demonstrate that both myc exon 2-and exon 3-mediated mRNA downregulation affects cytoplasmic mRNA levels but not nuclear mRNA levels.
DISCUSSION
Posttranscriptional mechanisms have been shown to play an important role in regulating c-myc expression (6, 13-15, 30, 45) . We have been studying the mechanism by which c-myc mRNA is posttranscriptionally downregulated during C2C12 differentiation. While housekeeping gene mRNAs (e.g., rpL32 and glyceraldehyde-3-phosphate dehydrogenase gene mRNAs) can be modestly downregulated early in myoblast differentiation, c-myc mRNA is specifically targeted for much greater downregulation. Our studies identified cis-acting elements that target myc mRNA for downregulation. Using C2C12 cells stably transfected with mutant myc genes, we showed that removal of coding sequences from either exon 2 or exon 3, but not removal of introns or UTR sequences, abolished myc mRNA downregulation during differentiation. Fusion of either myc exon 2 or exon 3 coding sequences, but not myc 3Ј UTR, CAT, or rpL32 sequences, conferred downregulation on ␤-globin mRNA, an mRNA that is normally not downregulated. Interestingly, neither myc exon 2 nor exon 3 coding sequences were sufficient to confer regulation onto CAT mRNA, but fusion of both exons did confer downregulation. Finally, using an assay that compares the relative abundances of two mRNAs, we demonstrated that the downregulation mediated by myc coding sequences occurs in the cytoplasm and not in the nucleus.
Our results suggest that two regulatory elements, one in myc exon 2 and the other in exon 3, are necessary for normal myc mRNA downregulation during myoblast differentiation. Analyses of regulation of myc mRNAs and globin-myc fusion mRNAs presented a conundrum in which coding sequences from either myc exon alone downregulated globin mRNA but did not downregulate c-myc mRNA; both elements were necessary for myc mRNA downregulation. Our studies excluded the existence of a network of regulatory elements in c-myc mRNA, some having positive and some having negative modulatory effects. Putative negative modulatory elements would have to reside in exon 1, UTR, or intron sequences (i.e., outside regions in exon 2 and 3 that were capable of downregulating globin-myc fusion mRNAs). Analyses of mRNAs encoded by the myc(T/N) genes lacking exon 1, UTR, and intron sequences and by globin-myc fusion genes containing intron 2 and 3Ј UTR sequences failed to reveal inhibitory elements. Therefore, this puzzle is best explained by some feature of globin mRNA which enables it to complement or enhance the function of each of the myc regulatory elements. The special nature of globin mRNA is supported by the behavior of chimeric CAT mRNAs which, unlike chimeric globin mRNAs, require both myc exons 2 and 3 to be fused for regulation. In addition, we previously demonstrated that using globin mRNA as a fusion partner can reveal the mRNA destabilizing effect of myc exon 3 sequences which is inapparent in its authentic myc context in proliferating C2C12 cells (47) . These results invite caution in the interpretation of results obtained with chimeric mRNAs, since unsuspected regulatory functions may be unmasked when mRNAs thought to be inert are fused to heter- FIG. 6 . myc intron 2 and 3Ј UTR sequences do not inhibit mRNA downregulation during myoblast differentiation. Differentiation assays were conducted on C2C12 cells stably transfected with ␤Gm40G(⌬41-178) or ␤Gm40G(⌬265-433). (See the legend in Fig. 2 for details of the assay.) Autoradiographs of Northern blots display mRNA levels in cells transfected with ␤Gm40G(⌬41-178) (A) and ␤Gm40G(⌬265-433) (B). mRNA from the transfected gene was detected by using a full-length human ␤-globin (␤G) cDNA probe, pSP␤c; endogenous murine c-myc and rpL32 mRNAs were detected by using myc exon 2 and 3 and full-length rpL32 probes, respectively. RNA from untransfected C2C12 cells (lanes U) was used to demonstrate specificity of the human ␤-globin cDNA probe. The bar graphs depict the levels of endogenous murine c-myc mRNA (dark bars) and transgene mRNA (light bars) relative to their mRNA levels in preconfluent, undifferentiated cells after normalization for RNA loading by reference to the level of rpL32 mRNA.
ologous sequences or placed in a different context. We point out, however, that myc mRNA regulatory functions revealed through fusion to globin mRNA have not been false. Rather, globin mRNA fusion seems to accentuate or exaggerate the regulatory function of segments of myc mRNA; thus far, we have been able to verify the function of these segments by other means.
It is unclear how exon 2 and 3 coding sequences modulate regulation during differentiation and whether these elements are targeted by independent mechanisms or by a single com- . mRNA from the transfected gene was detected by using a full-length CAT cDNA probe; endogenous murine c-myc and rpL32 mRNAs were detected by using a murine myc exon 1 probe and full-length rpL32 probe, respectively. RNA from untransfected C2C12 cells (lanes U) was used to demonstrate specificity of the CAT cDNA probe. The bar graphs depict the levels of endogenous murine c-myc mRNA (dark bars) and transgene mRNA (light bars) relative to their mRNA levels in preconfluent, undifferentiated cells after normalization for RNA loading by reference to the level of rpL32 mRNA. Ϫ and ␤Gm434SVpA or with ␤Gm(40-263)SVpARI Ϫ and ␤Gm434SVpA. Cytoplasmic (C) and nuclear (N) RNAs were extracted from preconfluent cells (P) and from cells allowed to grow to confluence and induced to differentiate for 2 days in differentiation medium (D). Comparative levels of mRNAs from the ␤-globin-myc genes were determined by RT-PCRϩ1, and the products were resolved on a 6% denaturing polyacrylamide gel. Autoradiographs display the following RT-PCRϩ1 products: undigested RT-PCRϩ1 products (lanes 1, 2, and 7 to 11) and EcoRI-digested RT-PCRϩ1 products (lanes 3 to 6 and 12). EcoRI-digested RT-PCRϩ1 products were spiked with the EcoRI cutting control prior to digestion. mon mechanism. We previously demonstrated that the rate of c-myc transcription from its own or the MLV LTR promoter is unchanged during C2C12 differentiation (45) . Therefore, mRNA downregulation is likely to occur through either accelerated mRNA decay or altered nuclear mRNA processing. We could address the issue of the cellular location of myc mRNA downregulation through use of a highly sensitive and specific RT-PCR-based method for comparing the levels of two mRNAs by using a reference mRNA that is not downregulated during C2C12 differentiation. In undifferentiated C2C12 cells, comparative levels of a globin-myc fusion mRNA containing the exon 2 regulatory element and a globin-myc fusion mRNA lacking either myc regulatory element were identical in the nucleus and cytoplasm, suggesting that their cytoplasmic turnover rates are similar. After cells were induced to differentiate, the relative nuclear levels of their spliced mRNAs did not change, but the cytoplasmic level of the myc exon 2-containing fusion mRNA markedly decreased relative to the level of the fusion mRNA lacking myc regulatory elements. Considered with the unchanged rate of transcription (45), these results demonstrate that downregulation during C2C12 differentiation is a postnuclear event and suggest that turnover of myc exon 2-containing mRNAs is accelerated after differentiation. Our assay is unable to distinguish whether this occurs in the cytoplasm or during nuclear-cytoplasmic transport of the mRNA. The cellular location of myc exon 3-mediated mRNA downregulation was similarly identified. Unlike myc exon 2, exon 3 destabilizes a globin-myc fusion mRNA even in undifferentiated cells. Compared to a globin-myc fusion mRNA lacking any myc regulatory element, myc exon 3-containing globin fusion mRNA was twofold less abundant in the cytoplasm than in the nucleus of undifferentiated C2C12 cells, suggesting that its cytoplasmic turnover rate is faster. After differentiation, the nuclear mRNA ratio is unchanged, but the drop in cytoplasmic mRNA ratio becomes more pronounced, demonstrating that myc exon 3-mediated downregulation, like that of exon 2, is a postnuclear event probably resulting from accelerated mRNA decay. While it is unclear whether exons 2 and 3 contain simply redundant regulatory elements or are targeted by independent mechanisms, our results demonstrate that both elements target mRNA for downregulation through postnuclear events.
Our results suggest that sequences from myc exon 2 and 3 likely mediate mRNA downregulation by destabilizing the mRNA under differentiation conditions. Coding sequences from myc exon 3 were previously implicated as a destabilizing element through in vitro mRNA decay assays (5, 26) and through study of c-myc mRNA induction after inhibiting translation with cycloheximide (46) . After treatment of cells with cycloheximide, levels of c-myc mRNA are rapidly and markedly induced. There is little change in the rate of c-myc transcription, and induction results from mRNA stabilization and depends on its rapid turnover prior to stabilization. Exon 3 coding sequences were found to be both necessary and sufficient for cycloheximide inducibility of myc mRNA, suggesting that they determine translation-dependent instability of c-myc mRNA (46) . Analyses of comparative steady-state mRNA levels also demonstrated that exon 3 coding sequences can act as an instability determinant under certain conditions. While they were dispensable for myc mRNA instability under growth conditions, their fusion to globin mRNA accelerated turnover of the fusion mRNA (47). Lavenu et al. also have suggested that exon 3 coding sequences are important determinants of posttranscriptional regulation of c-myc mRNA. Based on transgenic mouse studies, they believe that these sequences are responsible for tissue-specific patterns of c-myc mRNA expression as well as induction of c-myc mRNA in regenerating liver and after cycloheximide administration (32) . Their results suggest that these sequences have a destabilizing effect that can be regulated under growth conditions, e.g., during liver regeneration, to allow higher levels of expression. Similarly, our data suggest that exon 3 coding sequences contain a conditional instability determinant that functions during C2C12 differentiation and mediates myc mRNA downregulation by destabilizing the mRNA.
Exon 2 sequences also target myc mRNA for downregulation, presumably by destabilizing the mRNA during differentiation. Previous studies examining cycloheximide inducibility of myc mRNA (46), mRNA decay rates after inhibition of transcription with actinomycin D (27) , and analyses of comparative steady-state mRNA levels (47) failed to reveal the presence of a destabilizing element in exon 2. However, results of studies using global inhibitors of transcription or translation may be confounded by artifact, as has been demonstrated in studies of c-fos (43) and c-myc (46) mRNA metabolism. Previous comparisons of steady-state levels of myc or globin-myc fusion mRNAs deleting or fusing exon 2 sequences, which failed to reveal a destabilizing effect of these sequences, were carried out only under growth conditions (47) . Results of studies presented here suggest that exon 2 sequences contain an instability determinant that is operative only under special conditions of cell or tissue differentiation. Interestingly, exon 2 sequences were previously implicated in the posttranscriptional regulation of c-myc mRNA by studies demonstrating that they determined tissue-specific expression of c-myc mRNA and inducibility of c-myc mRNA during liver regeneration and cycloheximide treatment (32) through a mechanism that did not depend on their translation (40) . Our results suggest that myc exon 2 coding sequences also play an important role in the posttranscriptional downregulation of c-myc mRNA during myogenesis. In contrast to what was found in the liver, however, the ability of myc exon 2 (or exon 3) sequences to confer downregulation on globin mRNA in differentiating myoblasts requires their translation (unpublished observations).
In conclusion, we have examined the posttranscriptional regulation of mRNAs encoded by mutant myc and chimeric globin-myc and CAT-myc fusion genes to determine the cis-acting elements targeting c-myc mRNA for downregulation during C2C12 differentiation. Our data demonstrate that two elements, one in myc exon 2 and the other in the protein coding domain of myc exon 3, are both necessary for myc mRNA downregulation. While neither element alone is sufficient for downregulating myc or CAT-myc fusion mRNAs, either alone can confer downregulation when fused to ␤-globin mRNA. Finally, we demonstrate that mRNA downregulation does not result from altered nuclear processing but occurs as a result of postnuclear accelerated mRNA turnover.
